The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.
SPDR® S&P Biotech ETF XBI
Morningstar’s Analysis XBI
Will XBI outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 16.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novavax Inc | 3.10 | 209.1 Mil | Healthcare |
Insmed Inc | 2.27 | 153.1 Mil | Healthcare |
Moderna Inc | 1.63 | 109.9 Mil | Healthcare |
Natera Inc | 1.37 | 92.4 Mil | Healthcare |
Revolution Medicines Inc Ordinary Shares | 1.31 | 88.5 Mil | Healthcare |
Dyne Therapeutics Inc Ordinary Shares | 1.30 | 87.6 Mil | Healthcare |
Blueprint Medicines Corp | 1.27 | 86.1 Mil | Healthcare |
PTC Therapeutics Inc | 1.27 | 85.9 Mil | Healthcare |
BioCryst Pharmaceuticals Inc | 1.24 | 84.1 Mil | Healthcare |
United Therapeutics Corp | 1.23 | 83.2 Mil | Healthcare |